Suicide risk during anticonvulsant treatment. 2010

Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. maurizio.pompili@uniroma1.it

Recent research findings suggest possible increases in risk of suicidal behaviors among patients treated with anticonvulsants. The available evidence appears to support such a risk more clearly for patients diagnosed with epilepsy rather than with primary psychiatric disorders. However, the studies involved are limited by providing associational findings that may be confounded by several uncontrolled variables. Such limitations should be considered in future research on adverse effects of anticonvulsants and other centrally acting drugs. For now, however, clinical prudence calls for routine, ongoing assessment of mood and suicidal thoughts among neurological or psychiatric patients, whether or not treated with particular drugs.

UI MeSH Term Description Entries
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D013405 Suicide The act of killing oneself. Suicides
D015999 Multivariate Analysis A set of techniques used when variation in several variables are studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables. Analysis, Multivariate,Multivariate Analyses
D017891 Pharmacoepidemiology The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1)) Epidemiology, Pharmaceutical,Pharmaceutical Epidemiology,Epidemiologies, Pharmaceutical,Pharmaceutical Epidemiologies

Related Publications

Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
January 2006, The American journal of psychiatry,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
January 1999, The Journal of clinical psychiatry,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
April 2010, JAMA,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
January 2000, The Journal of clinical psychiatry,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
April 1961, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
January 1973, German medicine,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
April 1971, Revue medicale de la Suisse romande,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
March 1965, Epilepsia,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
September 2003, JAMA,
Maurizio Pompili, and Roberto Tatarelli, and Paolo Girardi, and Leonardo Tondo, and Ross J Baldessarini
February 2010, L'Encephale,
Copied contents to your clipboard!